• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结构导向的突变改变去泛素化活性并减轻一种鼠冠状病毒的发病机制。

Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.

机构信息

Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.

Department of Biological Sciences, Purdue University, West Lafayette, Indiana, USA.

出版信息

J Virol. 2020 May 18;94(11). doi: 10.1128/JVI.01734-19.

DOI:10.1128/JVI.01734-19
PMID:32188728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7269429/
Abstract

Coronaviruses express a multifunctional papain-like protease, termed papain-like protease 2 (PLP2). PLP2 acts as a protease that cleaves the viral replicase polyprotein and as a deubiquitinating (DUB) enzyme which removes ubiquitin (Ub) moieties from ubiquitin-conjugated proteins. Previous studies implicated PLP2/DUB activity as a negative regulator of the host interferon (IFN) response, but the role of DUB activity during virus infection was unknown. Here, we used X-ray structure-guided mutagenesis and functional studies to identify amino acid substitutions within the ubiquitin-binding surface of PLP2 that reduced DUB activity without affecting polyprotein processing activity. We engineered a DUB mutation (Asp1772 to Ala) into a murine coronavirus and evaluated the replication and pathogenesis of the DUB mutant virus (DUBmut) in cultured macrophages and in mice. We found that the DUBmut virus replicates similarly to the wild-type (WT) virus in cultured cells, but the DUBmut virus activates an IFN response at earlier times compared to the wild-type virus infection in macrophages, consistent with DUB activity negatively regulating the IFN response. We compared the pathogenesis of the DUBmut virus to that of the wild-type virus and found that the DUBmut-infected mice had a statistically significant reduction ( < 0.05) in viral titer in liver and spleen at day 5 postinfection (d p.i.), although both wild-type and DUBmut virus infections resulted in similar liver pathology. Overall, this study demonstrates that structure-guided mutagenesis aids the identification of critical determinants of the PLP2-ubiquitin complex and that PLP2/DUB activity plays a role as an interferon antagonist in coronavirus pathogenesis. Coronaviruses employ a genetic economy by encoding multifunctional proteins that function in viral replication and also modify the host environment to disarm the innate immune response. The coronavirus papain-like protease 2 (PLP2) domain possesses protease activity, which cleaves the viral replicase polyprotein, and also DUB activity (deconjugating ubiquitin/ubiquitin-like molecules from modified substrates) using identical catalytic residues. To separate the DUB activity from the protease activity, we employed a structure-guided mutagenesis approach and identified residues that are important for ubiquitin binding. We found that mutating the ubiquitin-binding residues results in a PLP2 that has reduced DUB activity but retains protease activity. We engineered a recombinant murine coronavirus to express the DUB mutant and showed that the DUB mutant virus activated an earlier type I interferon response in macrophages and exhibited reduced replication in mice. The results of this study demonstrate that PLP2/DUB is an interferon antagonist and a virulence trait of coronaviruses.

摘要

冠状病毒表达一种多功能的木瓜蛋白酶样蛋白酶,称为木瓜蛋白酶样蛋白酶 2(PLP2)。PLP2 作为一种蛋白酶,可切割病毒复制酶多蛋白,作为去泛素化(DUB)酶,可从泛素化缀合蛋白上去除泛素(Ub)部分。先前的研究表明,PLP2/DUB 活性是宿主干扰素(IFN)反应的负调节剂,但病毒感染期间 DUB 活性的作用尚不清楚。在这里,我们使用 X 射线结构引导的诱变和功能研究来鉴定 PLP2 中泛素结合表面内的氨基酸取代,这些取代降低了 DUB 活性而不影响多蛋白加工活性。我们将 DUB 突变(天冬氨酸 1772 突变为丙氨酸)引入鼠冠状病毒中,并在培养的巨噬细胞中和小鼠中评估 DUB 突变病毒(DUBmut)的复制和发病机制。我们发现,DUBmut 病毒在培养细胞中的复制与野生型(WT)病毒相似,但与 WT 病毒感染巨噬细胞相比,DUBmut 病毒更早地激活 IFN 反应,这与 DUB 活性负调控 IFN 反应一致。我们比较了 DUBmut 病毒和 WT 病毒的发病机制,发现 DUBmut 感染的小鼠在感染后 5 天(d p.i.)肝和脾中的病毒滴度有统计学意义的降低(<0.05),尽管 WT 和 DUBmut 病毒感染均导致相似的肝病理。总体而言,这项研究表明,结构引导的诱变有助于确定 PLP2-泛素复合物的关键决定因素,并且 PLP2/DUB 活性在冠状病毒发病机制中作为干扰素拮抗剂发挥作用。冠状病毒通过编码在病毒复制中起作用的多功能蛋白并修饰宿主环境来解除先天免疫反应,从而采用遗传经济性。冠状病毒的木瓜蛋白酶样蛋白酶 2(PLP2)结构域具有蛋白酶活性,可切割病毒复制酶多蛋白,还具有 DUB 活性(使用相同的催化残基从修饰的底物上去除泛素/泛素样分子)。为了将 DUB 活性与蛋白酶活性分开,我们采用了一种结构引导的诱变方法,并鉴定了对泛素结合很重要的残基。我们发现,突变泛素结合残基会导致具有降低的 DUB 活性但保留蛋白酶活性的 PLP2。我们设计了一种表达 DUB 突变的重组鼠冠状病毒,并表明 DUB 突变病毒在巨噬细胞中更早地激活 I 型干扰素反应,并在小鼠中表现出复制减少。这项研究的结果表明,PLP2/DUB 是一种干扰素拮抗剂,也是冠状病毒的毒力特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/95dcfba90a18/JVI.01734-19-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/4042f1fb94eb/JVI.01734-19-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/48ff1dbc9d84/JVI.01734-19-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/d9aa0d01c76b/JVI.01734-19-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/9f2923ad63a8/JVI.01734-19-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/ad22a2bdb804/JVI.01734-19-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/95dcfba90a18/JVI.01734-19-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/4042f1fb94eb/JVI.01734-19-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/48ff1dbc9d84/JVI.01734-19-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/d9aa0d01c76b/JVI.01734-19-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/9f2923ad63a8/JVI.01734-19-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/ad22a2bdb804/JVI.01734-19-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da8/7269429/95dcfba90a18/JVI.01734-19-f0006.jpg

相似文献

1
Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.结构导向的突变改变去泛素化活性并减轻一种鼠冠状病毒的发病机制。
J Virol. 2020 May 18;94(11). doi: 10.1128/JVI.01734-19.
2
Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.冠状病毒内切核糖核酸酶和去泛素化干扰素拮抗剂在巨噬细胞复制过程中对宿主反应的调节作用不同。
J Virol. 2020 May 18;94(11). doi: 10.1128/JVI.00178-20.
3
Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells.动脉病毒木瓜蛋白酶样蛋白酶 2 的去泛素化酶功能抑制感染宿主细胞中的固有免疫反应。
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):E838-47. doi: 10.1073/pnas.1218464110. Epub 2013 Feb 11.
4
Murine coronavirus ubiquitin-like domain is important for papain-like protease stability and viral pathogenesis.鼠冠状病毒泛素样结构域对木瓜样蛋白酶稳定性和病毒致病性很重要。
J Virol. 2015 May;89(9):4907-17. doi: 10.1128/JVI.00338-15. Epub 2015 Feb 18.
5
Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases.冠状病毒木瓜蛋白酶样蛋白酶的去泛素化和干扰素拮抗活性。
J Virol. 2010 May;84(9):4619-29. doi: 10.1128/JVI.02406-09. Epub 2010 Feb 24.
6
Analysis of Coronavirus Temperature-Sensitive Mutants Reveals an Interplay between the Macrodomain and Papain-Like Protease Impacting Replication and Pathogenesis.冠状病毒温度敏感突变体分析揭示了宏结构域和木瓜样蛋白酶之间的相互作用,影响病毒的复制和发病机制。
J Virol. 2019 May 29;93(12). doi: 10.1128/JVI.02140-18. Print 2019 Jun 15.
7
Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression.与泛素结合的中东呼吸综合征冠状病毒(MERS-CoV)木瓜样蛋白酶的晶体结构有助于靶向破坏去泛素化活性,以证明其在先天免疫抑制中的作用。
J Biol Chem. 2014 Dec 12;289(50):34667-82. doi: 10.1074/jbc.M114.609644. Epub 2014 Oct 15.
8
Protein interferon-stimulated gene 15 conjugation delays but does not overcome coronavirus proliferation in a model of fulminant hepatitis.蛋白干扰素刺激基因 15 缀合延迟但不能克服暴发性肝炎模型中的冠状病毒增殖。
J Virol. 2014 Jun;88(11):6195-204. doi: 10.1128/JVI.03801-13. Epub 2014 Mar 19.
9
Demonstrating the importance of porcine reproductive and respiratory syndrome virus papain-like protease 2 deubiquitinating activity in viral replication by structure-guided mutagenesis.通过结构指导的诱变证明猪繁殖与呼吸综合征病毒木瓜蛋白酶样蛋白酶 2 去泛素化活性在病毒复制中的重要性。
PLoS Pathog. 2023 Dec 14;19(12):e1011872. doi: 10.1371/journal.ppat.1011872. eCollection 2023 Dec.
10
PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathway.鼠肝炎病毒 A59(MHV-A59)的 PLP2 靶向 TBK1 以负调控细胞 I 型干扰素信号通路。
PLoS One. 2011 Feb 18;6(2):e17192. doi: 10.1371/journal.pone.0017192.

引用本文的文献

1
Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates.喹啉类新型冠状病毒木瓜样蛋白酶抑制剂作为口服抗病毒候选药物的设计
Nat Commun. 2025 Feb 13;16(1):1604. doi: 10.1038/s41467-025-56902-x.
2
Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing.基于生物信息学的 SARS-CoV-2 感染与特发性肺纤维化(IPF)疾病之间遗传影响的研究,以及药物再利用。
Sci Rep. 2023 Mar 22;13(1):4685. doi: 10.1038/s41598-023-31276-6.
3
Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase.

本文引用的文献

1
Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.冠状病毒内切核糖核酸酶和去泛素化干扰素拮抗剂在巨噬细胞复制过程中对宿主反应的调节作用不同。
J Virol. 2020 May 18;94(11). doi: 10.1128/JVI.00178-20.
2
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
3
A pneumonia outbreak associated with a new coronavirus of probable bat origin.
通过靶向失活免疫逃避病毒去泛素化酶来工程强效活减毒冠状病毒疫苗。
Nat Commun. 2023 Feb 28;14(1):1141. doi: 10.1038/s41467-023-36754-z.
4
A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2.采用计算本质动力学方法研究 SARS-CoV-2 木瓜蛋白酶样蛋白酶配体结合对结构的影响。
Comput Biol Chem. 2022 Aug;99:107721. doi: 10.1016/j.compbiolchem.2022.107721. Epub 2022 Jun 28.
5
Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development.干扰素对人冠状病毒感染的控制和病毒逃逸:作用机制的洞察及其对抗病毒药物和疫苗开发的意义。
J Mol Biol. 2022 Mar 30;434(6):167438. doi: 10.1016/j.jmb.2021.167438. Epub 2022 Jan 3.
6
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies.SARS-CoV-2 Nsp3 蛋白酶活性的生化特性及其纳米抗体抑制作用。
PLoS One. 2021 Jul 16;16(7):e0253364. doi: 10.1371/journal.pone.0253364. eCollection 2021.
7
The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.SARS-CoV-2 与 COVID-19 免疫病理的免疫反应——当前观点。
Pulmonology. 2021 Sep-Oct;27(5):423-437. doi: 10.1016/j.pulmoe.2021.03.008. Epub 2021 Apr 9.
8
Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants.利用 DockThor-VS 网络服务器进行药物设计和再利用,重点关注 SARS-CoV-2 的治疗靶点及其非同义变体。
Sci Rep. 2021 Mar 10;11(1):5543. doi: 10.1038/s41598-021-84700-0.
9
Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019.以巨噬细胞为靶点作为2019冠状病毒病的一种治疗选择
Front Pharmacol. 2020 Oct 29;11:577571. doi: 10.3389/fphar.2020.577571. eCollection 2020.
10
P53 in the impaired lungs.P53 在受损的肺脏中。
DNA Repair (Amst). 2020 Nov;95:102952. doi: 10.1016/j.dnarep.2020.102952. Epub 2020 Aug 19.
一种新型冠状病毒引发的肺炎疫情,该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
4
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
5
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
6
The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species.木瓜蛋白酶样蛋白酶决定了 SARS 冠状病毒种成员之间存在的一种毒力特征。
PLoS Pathog. 2018 Sep 24;14(9):e1007296. doi: 10.1371/journal.ppat.1007296. eCollection 2018 Sep.
7
Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines.联合衰减为活减冠状病毒疫苗提供策略。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.00710-18. Print 2018 Sep 1.
8
Structure and Function of Viral Deubiquitinating Enzymes.病毒去泛素化酶的结构与功能
J Mol Biol. 2017 Nov 10;429(22):3441-3470. doi: 10.1016/j.jmb.2017.06.010. Epub 2017 Jun 16.
9
Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages.冠状病毒非结构蛋白 15 介导逃避 dsRNA 传感器并限制巨噬细胞中的细胞凋亡。
Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4251-E4260. doi: 10.1073/pnas.1618310114. Epub 2017 May 8.
10
Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication.早期核酸内切酶介导的RNA传感逃避确保了冠状病毒的有效复制。
PLoS Pathog. 2017 Feb 3;13(2):e1006195. doi: 10.1371/journal.ppat.1006195. eCollection 2017 Feb.